Tae-Jung Kim is the head of molecular pathology at Yeouido St. Mary's Hospital. As a member of the academic committee of the Korean Association of Lung Cancer and ISALC, he organizes many biomarker studies and trials and subsequent platform settings in South Korea and Asia. His major academic interests include cancer genomics, biomarkers, analytic test platforms, target therapy and companion diagnostics, and immunotherapy.